Alvotech (ALVO) Accumulated Expenses (2021 - 2023)
Alvotech's (ALVO) quarterly Accumulated Expenses came in at $14.5 million in Q2 2023, down 22.44% quarter-over-quarter from $18.7 million in Q4 2022.
Analysis
Alvotech (ALVO) Accumulated Expenses (2021 - 2023) Analysis & Trends
Alvotech (ALVO) has reported Accumulated Expenses for 3 consecutive years, with $14.5 million the latest figure, recorded in Q2 2023.
- For the quarter ending Q2 2023, Accumulated Expenses changed N/A year-over-year to $14.5 million; the trailing twelve-month figure through Jun 2023 stood at $14.5 million (changed N/A YoY), and the FY2022 full-year result was $18.7 million, up 291.22% from the prior year.
- Accumulated Expenses declined to $14.5 million in Q2 2023 per ALVO's latest filing, from $18.7 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $18.7 million in Q4 2022 and bottomed at $4.8 million in Q4 2021.
- Historically, Accumulated Expenses has averaged $12.7 million across 3 years, with a median of $14.5 million in 2023.
- The widest YoY moves for Accumulated Expenses: up 291.22% in 2022, down 291.22% in 2022.
- Over 3 years, Accumulated Expenses stood at $4.8 million in 2021, then surged by 291.22% to $18.7 million in 2022, then decreased by 22.44% to $14.5 million in 2023.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $14.5 million, $18.7 million, and $4.8 million for Q2 2023, Q4 2022, and Q4 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 14.52 Mn |
| Dec 31, 2022 | 18.72 Mn |
| Dec 31, 2021 | 4.79 Mn |